Pancreatic perforation caused by the Soehendra짰 retrieval device in a patient with chronic pancreatitis by �옣�꽦�씪 et al.
Gastrointestinal Intervention
journal homepage: www.gi-intervention.org
Gastrointest Interv 2017;6:187–190
Complication Forum
Pancreatic perforation caused by the Soehendra® retrieval device in 
a patient with chronic pancreatitis
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Summary of Event: An endoscopic retrograde pancreatic duct (ERPD) stent was inserted in a male patient with chronic pancreatitis via endoscopic 
retrograde cholangiopancreatography (ERCP) to relieve chronic epigastric pain. After the procedure, an abdominal computed tomography scan 
showed localized peritonitis with a dislocated ERPD stent. The patient underwent an emergency operation, which revealed that the peritonitis was 
caused by perforation of the pancreatic parenchyma by the ERPD stent. 
Teaching Point: A hydrophilic guide wire can puncture the pancreas during ERPD stent insertion. Therefore, it is necessary to ensure that the guide 
wire reaches the main pancreatic duct, especially in patients with chronic pancreatitis.
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Event Details
A 69-year-old male was admitted to our hospital with wors-
ening severe epigastric pain. The patient was diagnosed with hy-
pertension and was taking oral calcium channel blocker. He had 
undergone endoscopic retrograde pancreatic duct (ERPD) stent 
insertion and removal for alcohol-induced pancreatitis 15 years 
prior and laparoscopic cholecystectomy for gallbladder stones 1 
month prior. On admission, an abdominal computed tomography 
(CT) scan showed marked atrophic changes in the body and tail 
of the pancreas with tiny calcified parenchymal stones and ~1.2 
cm dilatation of the main pancreatic duct (Fig. 1). We performed 
endoscopic retrograde cholangiopancreatography (ERCP) and 
insertion of an ERPD stent to decompress the pancreatic duct to 
resolve his abdominal pain (Fig. 2). The pancreatogram showed a 
very tight stricture of the main pancreatic duct at the head por-
tion. During cannulation, the guide wire barely passed through 
the main pancreatic duct. We inserted a Soehendra® bougie dila-
tor (4–6 Fr; Cook Medical, Bloomington, IN, USA), but it failed 
to pass the stricture. Dilating the stricture by drilling using a 
Soehendra® retrieval device (7 Fr; Cook Medical) was successful, 
and an ERPD plastic stent (7 Fr/10 cm, single pigtail; Cook Medi-
cal) was inserted into the main pancreatic duct along the guide 
wire. However, the patient complained of persistent abdominal 
pain after the procedure. At this time, his blood results were as 
follows: C-reactive protein 10 mg/L, total bilirubin 2.5 mg/dL, 
alkaline phosphatase 391 IU/L, aspartate aminotransferase/ala-
nine aminotransferase 324/401 IU/L, gamma glutamyl transferase 
694 IU/L, amylase 174 IU/L, and lipase 82 U/L. We performed a 
second ERCP and inserted an endoscopic retrograde biliary drain-
age (ERBD) stent because of suspicion of a common bile duct 
obstruction by acute aggravation of chronic pancreatitis (Fig. 3). 
However, the patient continued to complain of abdominal pain. 
He underwent abdominal CT, which showed localized peritonitis 
with pneumoperitoneum in the retroperitoneum, likely due to 
perforation by the ERPD stent. An emergency operation was per-
formed, during which we found that the head portion of the pan-
creas was punctured by the ERPD stent (Fig. 4). Therefore, a total 
pancreatectomy was performed. The patient recovered after the 
operation and was discharged. He has since been monitored on an 
outpatient basis.
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Discussion
During ERCP, guide wires are used to reach the biliary, pan-
creatic, cystic or intrahepatic duct.1,2 Perforation and failed device 
placement are the major wire-related risks of wire-guided pro-
cedures in the pancreas or biliary tree.3 Four types of perforation 
complicating ERCP have been recognized; type III is extramural 
passage of guide wires or migration of stents. Type I perforation 
is luminal perforation by the endoscope, usually resulting in in-
traperitoneal perforation; type II is extension of a sphincterotomy 
beyond the intramural portion of the bile or pancreatic duct with 
retroperitoneal leakage; and type IV is retroperitoneal air only. 
According to the numerous, primarily retrospective, studies pub-
lished from 1999 to 2014, type III perforations account for 22%, 
type I for 25%, type II for 46%, and type IV for 3% of the total 
cases of perforation.4 The risk factors for perforation are anatomi-
Fig. 2. Endoscopic retrograde pancreatic duct (ERPD) stent insertion. (A) Pancreatogram by endoscopic retrograde cholangiopancreatography (ERCP) shows pancre-
atic duct stenosis due to an intraductal stone in a patient with chronic pancreatitis. (B) The guide wire was advanced and passed through the stenosis in the pan-
creatic duct. (C) We attempted to dilute the stricture site using a bougie dilator along the guide wire, but failed. (D) The stricture site was dilated using a Soehendra® 
retrieval device. (E) Dye was observed up to the tail portion of the pancreas on the pancreatogram. (F) An ERPD stent was inserted along the guide wire.
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Fig. 1. Computed tomography (CT) scans at admis-
sion. (A) CT scan showing numerous tiny calcified 
parenchymal or intraductal stones at the head 
portion of the pancreas (arrow). (B) Marked atro-
phic changes in the pancreas with tiny calcified 
parenchymal stones and a ~1.2 cm dilatation of 
the body and tail portions of the main pancreatic 
duct (arrow).
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cal deformities such as Billroth II anastomosis, endoscopic sphinc-
terotomy, and diverticulum of the ampulla, stenosis of the duct, a 
long procedure time, dysfunction of the sphincter of Oddi, and old 
age.5,6
It is classified as severe chronic pancreatitis according to the 
Cambridge classification, especially when accompanied by stric-
ture of the main pancreatic duct by intraductal calculi.7 European 
Society of Gastrointestinal Endoscopy recommends insertion of a 
single 10 Fr stent into the main pancreatic duct via ERCP, main-
tained for at least 1 year.8 Therefore, insertion of an ERPD stent 
using a guide wire is performed to maintain the flow of pancreatic 
juice. In general, the tip of the guide wire is of a soft, hydrophilic 
material and complications are very rare. However, wire-induced 
perforation can occur when excessive force is applied below a 
stricture or at an acute angle. Rigid devices can perforate when 
wire access is lost due to a stricture or a tortuous lumen, or when 
tension is lost, and the wire can no longer serve as a guide. In 
this case, we do not think that the hydrophilic guide wire caused 
perforation of the pancreatic duct and pancreatic parenchyma. 
However, the guide wire did not pass the severe stricture and 
moved to the uncinated duct, resulting in pancreatic perforation. 
Several cases of hepatic and pancreatic parenchymal perforation 
by the guide wire during ERCP have been reported.9 The patients 
with hepatic perforations underwent surgery, and the patient with 
a pancreatic perforation, which was induced incidentally during 
ERCP for removal of a common bile duct stone, recovered after 
conservative management. This is different from our case, in 
which perforation occurred during insertion of an ERPD stent in a 
patient with chronic pancreatitis involving a severe stricture.
Prevention 
The pancreatic parenchymal perforation by the guide wire 
during ERCP is a rare and under-appreciated complication. We re-
port a case of post-ERCP pancreatic parenchymal perforation by a 
hydrophilic guide wire in a patient with chronic pancreatitis. It is 
necessary to be ensure that the guide wire reaches the main pan-
creatic duct during the ERPD stent insertion, especially in the pa-
tients with severe chronic pancreatitis. Moreover, because difficult 
cannulation is associated with complications of ERCP,10 surgery is 
an alternative to endoscopic modalities as the initial treatment for 
patients with severe advanced chronic pancreatitis. 
Teaching Point
A hydrophilic guide wire can puncture the pancreas during 
ERPD stent insertion. Therefore, it is important to verify the posi-
tion of guide wire during insertion of ERPD stent in patients with 
severe stricture of main pancreatic duct. In addition, the pancre-
atic parenchymal perforation need to be evaluated if the patient 
with severe stricture of pancreatic duct complains of persistent 
abdominal pain after ERPD stent insertion. 
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Fig. 3. Clinical course after endoscopic retrograde 
cholangiopancreatography (ERCP). (A) Abdominal 
pain persisted until day 2 after ERCP, when mild 
gas distension was observed on abdominal x-ray, 
but no ileus was detected. (B) Hepatic function was 
decreased and the total bilirubin level increased; 
thus, an endoscopic retrograde biliary drainage 
(ERBD) stent was inserted. (C) On day 4 after the 
initial ERCP, the patient’s abdominal pain was ex-
acerbated, and computed tomography revealed lo-
calized peritonitis with pneumoperitoneum in the 
retroperitoneum. (D) Distal tip of the endoscopic 
retrograde pancreatic duct (ERPD) stent located in 
the left anterior pararenal space (arrow) and high-
density fluids near the ERPD stent with multiple 
air densities (arrowhead).
A B
C D
Gastrointestinal Intervention 2017 6(3), 187–190190
References
1. Husain A, Debold C, Edmundowicz SA, Jonnalagadda SS. Directed balloon-assist-
ed guidewire access into intrahepatic ducts. Gastrointest Endosc. 2001;54:118-9.
2. Moxon DR, Hong K, Brown RD, Venu RP. Selective intrahepatic ductal cannula-
tion during ERCP with a sphincterotome. Gastrointest Endosc. 2003;57:738-43.
3. Aliperti G. Complications related to diagnostic and therapeutic endoscopic retro-
grade cholangiopancreatography. Gastrointest Endosc Clin N Am. 1996;6:379-
407.
4. Vezakis A, Fragulidis G, Polydorou A. Endoscopic retrograde cholangiopancrea-
tography-related perforations: diagnosis and management. World J Gastrointest 
Endosc. 2015;7:1135-41. 
5. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications 
after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastroin-
test Endosc. 2009;70:80-8. 
6. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. 
Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909-
18.
7. Banks PA. Classification and diagnosis of chronic pancreatitis. J Gastroenterol. 
2007;42 Suppl 17:148-51.
8. Vitale GC, Cothron K, Vitale EA, Rangnekar N, Zavaleta CM, Larson GM, et al. 
Role of pancreatic duct stenting in the treatment of chronic pancreatitis. Surg En-
dosc. 2004;18:1431-4. 
9. Rabie ME, Al Faris S, Nasser A, Shahir AA, Al Mahdi Y, Youssef Al Asmari M. Pa-
renchymal guidewire perforation during ERCP: an unappreciated injury. Case Rep 
Surg. 2015;2015:670323. 
10. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: 
avoidance and management. Gastrointest Endosc Clin N Am. 2012;22:567-86. 
Fig. 4. Photographs of the operation and specimen. (A) Inflammation of the head portion of the pancreas was not severe. (B) An endoscopic retrograde pancreatic 
duct (ERPD) stent was observed during separation of the pancreas from surrounding tissues (arrow), and a total pancreatectomy was performed because of severe 
inflammation. (C) An ERPD stent perforating the pancreas was observed in the surgical specimen (arrow). (D) A perforated hole in the pancreatic duct was observed 
in a specimen obtained following removal of the ERPD stent (arrow).
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